Healthcare Group, a pharmaceutical firm, takes a methodical outlook to enterprise risk management. Throughout its value chain, from the early identification of new, promising compounds to the manufacture and distribution of drugs to patients, it is constantly exposed to risks. In the pharmaceutical industry, certain uncertainties are inevitable, such as delays or failures of promising new drugs in the R&D pipeline. Other challenges, such as supply disruptions and competitive threats, are well known to every global manufacturing organisation.
R&D risk, supply chain risk, safety and quality risks, commercialisation risk, security risk, financial risk and regulatory risk are some of the most significant threats that it faces.
Based on the given information, which framework is Healthcare Group more inclined to use as a base in its risk management process?
k management process?
ISO 31000
COSO
COBIT
None of the above
